Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
Business Summary
Number of employees: 41
Sales per Business
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
Anti-infective Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -36.62% |
Sales per region
USD in Million | 2006 | Weight | 2007 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -36.62% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John R. Barr
CEO | Chief Executive Officer | 67 | - |
Thomas Higgins
DFI | Director of Finance/CFO | 72 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 53,640,136 | 53,640,136 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Panacos Pharmaceuticals, Inc.
134 Coolidge Avenue
02472, Watertown
+
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 53 | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.03% | 21.96B | |
-9.14% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- PANC Stock
- Company Panacos Pharmaceuticals, Inc.